TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 196 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $5,994,000 | -12.1% | 125,653 | +22.4% | 0.12% | -14.9% |
Q3 2021 | $6,819,000 | -28.9% | 102,652 | -16.5% | 0.14% | -18.0% |
Q2 2021 | $9,595,000 | +4.6% | 122,983 | +26.8% | 0.17% | +1.2% |
Q1 2021 | $9,177,000 | -31.9% | 97,015 | -12.3% | 0.17% | -33.6% |
Q4 2020 | $13,475,000 | +55.8% | 110,585 | +11.7% | 0.26% | +11.8% |
Q3 2020 | $8,649,000 | – | 99,001 | – | 0.23% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
venBio Partners LLC | 708,233 | $44,116,000 | 18.91% |
Corriente Advisors, LLC | 285,000 | $17,753,000 | 9.54% |
Cormorant Asset Management, LP | 3,396,650 | $211,577,000 | 8.44% |
Opaleye Management Inc. | 340,500 | $21,210,000 | 4.16% |
Orbimed Advisors | 2,745,327 | $171,006,000 | 2.44% |
Parkman Healthcare Partners LLC | 101,434 | $6,318,000 | 1.82% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,179,000 | 0.78% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 366,000 | $22,798,000 | 0.73% |
Artal Group S.A. | 300,000 | $18,687,000 | 0.72% |
DAFNA Capital Management LLC | 30,408 | $1,894,000 | 0.65% |